生物标志物发现阶段的方法/方法
Nidhya Navanandan1, Justin Searns2,3,4, Lilliam Ambroggio1,2
1Sections of Emergency Medicine.
Hospital pediatrics
|June 15, 2023
概括
儿科生物标志物有助于疾病的识别和管理. 了解生物标志物发现,验证和临床应用对于儿科医生来说至关重要,以改善患者护理.
科学领域:
- 生物标志物研究和儿科医学.
背景情况:
- 生物标志物在儿科中对于疾病预测,诊断和预后至关重要.
- 样本采集和检测方法因疾病和可用性而异.
- 开发新的生物标志物包括目标识别,验证和测试特征的确定.
研究的目的:
- 概述儿科医学中的生物标志物发现和应用过程.
- 让儿科医生具备批判性评估和实施生物标志物的技能.
主要方法:
- 文献审查和生物标志物发展途径的合成.
- 讨论样本类型,方法和理想生物标志物特征.
- 现实世界案例示例的演示,用于实际应用.
主要成果:
- 生物标志物开发从发现和验证到临床测试和实施都在进行.
- 理想的生物标志物是可以获得的,可量化的,并且具有临床影响.
- 解释生物标志物表现是儿科医生必不可少的技能.
结论:
- 临床整合需要一种系统的生物标志物开发方法.
- 生物标志物的有效使用可以提高儿科的诊断准确性和患者管理.
- 持续学习和批判性评估是儿童医生使用生物标志物的关键.
更多相关视频
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
16.9K
13:00Low Molecular Weight Protein Enrichment on Mesoporous Silica Thin Films for Biomarker Discovery
Published on: April 17, 2012
13.5K
相关概念视频
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Drug Administration and Therapy Phases: Overview
562
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
562
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
